Patent · US Expired

Intra-tumoral administration of IL-12 encoding nucleic acid molecules

US7141550B2 · kind B2 · utility

6Cited by

0References

11Claims

0Family size

Assignee

Universität Zürich Institut für Medizinische Virologie · CH

Inventors

Karin Molling · Berlin, DE
Jan C.C. Schultz · Bellinzona, CH
Lucie Heinzerling · Bellinzona, CH

Key dates

Filing date	Dec 1, 2001
Grant date	Nov 28, 2006
Priority date	—
Expiry date	Mar 11, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is the use of a nucleic acid molecule encoding an IL-12 polypeptide for the preparation of a pharmaceutical composition for the treatment of a tumor, wherein the pharmaceutical composition is for intra-tumoral administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.